SCHEMBL10419484

SCHEMBL10419484

N#CC(c1ccc(F)cc1)c1c(Cl)cc([N+](=O)[O-])cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
LMNA P02545 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
ALPG P10696 2/20 0.44
VCAM1 P19320 3/20 0.41
HPGD P15428 2/20 0.40
USP2 O75604 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSPB1 P04792 1/20 0.37
MEN1 O00255 1/20 0.37
NR1I2 O75469 1/20 0.37
KMT2A Q03164 1/20 0.37
GPR35 Q9HC97 1/20 0.36
POLB P06746 1/20 0.35
PDE7A Q13946 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10421676 0.91 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2ALPGVCAM1
SCHEMBL8147067 0.88 MEN1 (0.46) ALDH1A1VCAM1HTTHSD17B10TDP1
SCHEMBL10419885 0.85 VCAM1 (0.44) ALDH1A1LMNASMN1; SMN2ALPGVCAM1
SCHEMBL10419927 0.84 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2ALPGVCAM1
SCHEMBL7840238 0.84 HSD17B10 (0.53) ALDH1A1LMNAVCAM1HSD17B10TDP1
SCHEMBL5561482 0.80 VCAM1 (0.40) ALDH1A1LMNASMN1; SMN2VCAM1HTT
SCHEMBL10421412 0.80 MEN1 (0.40) ALDH1A1VCAM1HSD17B10TDP1MEN1
SCHEMBL10672256 0.77 ALDH1A1 (0.46) ALDH1A1LMNASMN1; SMN2ALPGHPGD
SCHEMBL10421418 0.76 ALDH1A1 (0.43) ALDH1A1LMNASMN1; SMN2ALPGVCAM1
SCHEMBL5565988 0.76 MEN1 (0.39) ALDH1A1LMNAVCAM1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0170316-B1 ALPHA-ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN-2(3H)-YL)BENZENEACETONITRILES JANSSEN PHARMACEUTICA N.V. (BE) 1990-05-30 EP disclosed
US-4778887-A ANTIPROTOZOA AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 1988-10-18 US disclosed
US-4631278-A Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor JANSSEN PHARMACEUTICA N.V. (BE) 1986-12-23 US disclosed
EP-0170316-A2 alpha-Aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitriles JANSSEN PHARMACEUTICA N.V. (BE) 1986-02-05 EP disclosed